Irbesartan Powder APIse yon dwòg anti-ipètansif. Li se yon antagonis reseptè angiotensin II. Irbesartan gen aksyon, itilizasyon ak efè negatif menm jan ak losartan. Irbesartan ka itilize pou kont li oswa ak lòt API antihypertensive pou kontwole tansyon wo ak lòt maladi kadyovaskilè.
Pou ki sa irbesartan itilize?
Irbesartan se yon medikaman ki bloke reseptè anjyotansin (ARB).lajman itilize pou trete tansyon wo (tansyon wo). Li detann ak elaji veso sangen ou yo.
As with all angiotensin II receptor antagonists, Irbesartan is indicated for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 èdtan).
Irbesartan yo itilize pou trete tansyon wo.
Irbesartan yo itilize pou pwoteje fonksyon ren nan pasyan dyabetik ki gen pèt pwoteyin.
